Percutaneous coronary intervention in patients with diabetes: current concepts and future directions

Ehrin J Armstrong1, Johannes Waltenberger2, Jason H Rogers3

  • 1Davis Medical Center, Division of Cardiovascular Medicine, University of California, Sacramento, CA, USA ehrin.armstrong@gmail.com.

Insights

Diabetic patients with coronary artery disease face challenges in revascularization. While drug-eluting stents improve outcomes, insulin-treated patients remain high-risk, necessitating further innovation in coronary artery disease treatments.

Area of Science:

  • Cardiology
  • Endocrinology
  • Interventional Cardiology

Background:

  • Diabetes mellitus and coronary artery disease (CAD) frequently coexist, posing significant clinical challenges.
  • Surgical revascularization is preferred for diabetic patients with stable multivessel CAD, yet percutaneous coronary intervention (PCI) is often utilized due to comorbidities or acute presentations.
  • Drug-eluting stents (DES) have improved PCI outcomes in diabetics but persistent issues like restenosis and stent thrombosis remain.

Purpose of the Study:

  • To review the current landscape of percutaneous revascularization in patients with diabetes and coronary artery disease.
  • To highlight the differential outcomes based on diabetes management (insulin vs. non-insulin agents).
  • To discuss future directions and emerging technologies for improving PCI results in this high-risk population.

Main Methods:

  • Review of existing literature and clinical data on percutaneous coronary intervention in diabetic patients.
  • Comparative analysis of outcomes between diabetic patients treated with different revascularization strategies and medications.
  • Discussion of technological advancements in stent design and drug elution relevant to diabetic CAD.

Main Results:

  • PCI outcomes for diabetic patients on non-insulin agents have neared those of non-diabetic patients with current DES technology.
  • Diabetic patients requiring insulin therapy represent a high-risk group with elevated rates of target vessel failure post-revascularization.
  • Despite advancements, diabetic patients undergoing PCI still experience higher rates of restenosis and stent thrombosis compared to non-diabetics.

Conclusions:

  • While DES have enhanced PCI efficacy, significant challenges persist for diabetic patients, particularly those on insulin.
  • Future innovations, including bioresorbable stents and novel drug elution systems, hold promise for improving outcomes in this vulnerable cohort.
  • Optimizing revascularization strategies for diabetic patients with CAD remains a critical area for clinical research and development.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
17
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
443
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
51
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
487